학술논문
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Document Type
Article
Author
van de Donk, N.W.C.J.; Zweegman, S.; Minnema, M.C.; van der Holt, B.; Razawy, W.; Broijl, A.; Sonneveld, P.; Schjesvold, F.; Wu, K.L.; Roeloffzen, W.W.H.; Gadisseur, A.; Pietrantuono, G.; Pour, L.; van der Velden, V.H.J.; Lund, T.; Offidani, M.; Grasso, M.; Giaccone, L.; Tacchetti, P.; Mancuso, K.; Silkjaer, T.; Caers, J.; Hájek, R.; Benjamin, R.; Vangsted, A.J.; Boccadoro, M.; Gay, F.; Musto, P.
Source
In: The Lancet Oncology . (The Lancet Oncology, October 2023, 24(10):1119-1133)
Subject
Language
English
ISSN
14745488
14702045
14702045